Singapore · Delayed Price · Currency is SGD Pacific Radiance Statistics
Total Valuation
SGX:RXS has a market cap or net worth of SGD 77.35 million. The enterprise value is 69.92 million.
| Market Cap | 77.35M |
| Enterprise Value | 69.92M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | May 6, 2026 |
Share Statistics
SGX:RXS has 1.46 billion shares outstanding. The number of shares has increased by 9.73% in one year.
| Current Share Class | 1.46B |
| Shares Outstanding | 1.46B |
| Shares Change (YoY) | +9.73% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 69.50% |
| Owned by Institutions (%) | 4.43% |
| Float | 437.94M |
Valuation Ratios
The trailing PE ratio is 5.81 and the forward PE ratio is 4.19.
| PE Ratio | 5.81 |
| Forward PE | 4.19 |
| PS Ratio | 1.18 |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.63 |
| EV / Sales | 1.07 |
| EV / EBITDA | 5.31 |
| EV / EBIT | 11.66 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.90 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.74 |
| Debt / FCF | -8.88 |
| Interest Coverage | 13.78 |
Financial Efficiency
Return on equity (ROE) is 12.23% and return on invested capital (ROIC) is 4.11%.
| Return on Equity (ROE) | 12.23% |
| Return on Assets (ROA) | 2.04% |
| Return on Invested Capital (ROIC) | 4.11% |
| Return on Capital Employed (ROCE) | 3.63% |
| Weighted Average Cost of Capital (WACC) | 7.52% |
| Revenue Per Employee | 385,464 |
| Profits Per Employee | 88,744 |
| Employee Count | 170 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 5.39 |
Taxes
In the past 12 months, SGX:RXS has paid 160,467 in taxes.
| Income Tax | 160,467 |
| Effective Tax Rate | 1.05% |
Stock Price Statistics
The stock price has decreased by -36.59% in the last 52 weeks. The beta is 0.67, so SGX:RXS's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -36.59% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 25.57 |
| Average Volume (20 Days) | 925,885 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGX:RXS had revenue of SGD 65.53 million and earned 15.09 million in profits. Earnings per share was 0.01.
| Revenue | 65.53M |
| Gross Profit | 22.72M |
| Operating Income | 5.10M |
| Pretax Income | 15.27M |
| Net Income | 15.09M |
| EBITDA | 11.60M |
| EBIT | 5.10M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 16.31 million in cash and 9.06 million in debt, with a net cash position of 7.25 million or 0.00 per share.
| Cash & Cash Equivalents | 16.31M |
| Total Debt | 9.06M |
| Net Cash | 7.25M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 130.02M |
| Book Value Per Share | 0.09 |
| Working Capital | 44.52M |
Cash Flow
In the last 12 months, operating cash flow was -1.63 million and capital expenditures 606,928, giving a free cash flow of -1.02 million.
| Operating Cash Flow | -1.63M |
| Capital Expenditures | 606,928 |
| Depreciation & Amortization | 6.35M |
| Net Borrowing | -587,667 |
| Free Cash Flow | -1.02M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 34.67%, with operating and profit margins of 7.78% and 23.02%.
| Gross Margin | 34.67% |
| Operating Margin | 7.78% |
| Pretax Margin | 23.30% |
| Profit Margin | 23.02% |
| EBITDA Margin | 17.70% |
| EBIT Margin | 7.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 3.24%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 3.24% |
| Dividend Growth (YoY) | 250.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 17.18% |
| Buyback Yield | -9.73% |
| Shareholder Yield | -6.49% |
| Earnings Yield | 19.50% |
| FCF Yield | -1.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 12, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 12, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
SGX:RXS has an Altman Z-Score of 1.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 3 |